CAPR Capricor Therapeutics Inc
Company Analysis
Latest News
🟢 Capricor Therapeutics is trading 16.2% up in after-hours trading
Capricor Therapeutics is trading at $7.41 in after-hours trading, up 16.20% from the October 30 regular-session close of $6.38; no confirmed catalyst has been...
🔴 Capricor Therapeutics is trading 5.58% down; no confirmed company-specific explanation
Capricor Therapeutics is trading 5.58% lower at $6.25, with no confirmed company-specific announcement explaining the decline. - The decline followed a 6.42%...
🟢 Capricor Therapeutics is trading 11% up today — no confirmed catalyst
Capricor Therapeutics is trading at $6.93, up 11.24%; no clearly confirmed October 29 catalyst explains the rise. - A report covered final HOPE-2 results,...
🟢 Capricor Therapeutics is trading 6.1% up today
Capricor Therapeutics is trading at $6.61, up 6.10%, with no clearly confirmed catalyst directly explaining the October 29 move. - An October 29 report...
🟢 Capricor Therapeutics is trading 6% up
Capricor Therapeutics is trading at $6.08, up 6.01%, alongside a broader biotech rally; no direct catalyst for the October 27 move was identified. - The XBI...
🟢 Capricor Therapeutics is trading 5.78% up
Capricor Therapeutics is trading at $6.22, up 5.78%, with no clear company-specific catalyst identified for the gain on October 22. - Its investor news page...
🔴 Capricor Therapeutics is trading 5.6% down; immediate cause remains uncertain
Capricor Therapeutics is trading 5.6% down at $6.24, with no clear company-specific news explaining the October 21 decline. - Recent coverage highlighted...
🔴 Capricor Therapeutics is trading 6.05% down — no clear company-specific catalyst identified
Capricor Therapeutics is trading at $6.83, down 6.05%, with no clear company-specific catalyst identified for the October 16 decline. - Recent coverage...
Capricor Pops 10% on Recycled Trial Data — But Can a Conference Poster Overcome a 9-3 FDA Panel Rejection?
Shares of Capricor Therapeutics surged 10.3% to $7.27 on October 15, buoyed by renewed investor focus on clinical data presented at the World Muscle Society...
🟢 Capricor Therapeutics is trading 10% up today on HOPE-3 data at World Muscle Society congress
Capricor Therapeutics is trading 10.32% up now at $7.27 on October 15, 2026, as reports linked the advance to attention around its HOPE-3 open-label-extension...
🟢 Capricor Therapeutics is trading 5% up today amid biotech-sector strength
Capricor Therapeutics is trading at $6.93, up +5.16%, with biotech-sector strength potentially supportive; no new company-specific announcement explaining the...
🔴 Capricor Therapeutics is trading 6.5% down in pre-market amid inflation-driven risk-off pressure
Capricor Therapeutics is trading 6.47% down at $6.16 in pre-market on October 15 amid broader risk-off pressure following hotter-than-expected U.S....
🔴 Capricor Therapeutics is trading 5% down today amid biotech and broader-market weakness
Capricor Therapeutics is trading 5.09% lower at $6.53 amid biotech and broader-market weakness; no company-specific announcement explaining the decline was...
🔴 Capricor Therapeutics is trading 5% down in pre-market with no fresh company announcement identified
Capricor Therapeutics is trading 5.43% lower at $6.51 in pre-market on October 14, with no fresh company announcement identified to explain the move. - It...
🔴 Capricor Therapeutics is trading 5% down with no confirmed fresh catalyst
Capricor Therapeutics is trading 5.22% lower at $7.08, with no confirmed company announcement explaining the decline on October 13. - The biotech sector is...
Capricor’s Positive DMD Data Leads Oppenheimer to Reaffirm $54 Target
After Capricor Therapeutics’ October 7 webinar on new positive data for its Duchenne muscular dystrophy (DMD) treatment deramiocel, Oppenheimer reiterated its...
🟢 Capricor Therapeutics is trading 5.67% up with no clear catalyst identified
Capricor Therapeutics is trading at $8.19, up 5.67%, with no clear company-specific catalyst identified. - The company’s October 5 announcement reported...
🔴 Capricor Therapeutics is trading 10% down — reason for decline remains unclear
Capricor Therapeutics is trading 10% down at $8.05; the specific reason for the decline remains unclear. - On October 5, the company announced positive HOPE-3...
🔴 Capricor Therapeutics is trading 6.2% down; specific catalyst remains unclear
Capricor Therapeutics is trading 6.2% lower at $8.40, and the specific catalyst remains unclear. - No confirmed company-specific announcement or report on...
🔴 Capricor Therapeutics is trading 5.7% down
Capricor Therapeutics is trading at $8.94, down 5.65%, in an October 1 decline with no clear catalyst identified in available coverage. - The latest reported...